S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours

Autor: Annette Hasenburg, Gabriele Calaminus, Friedrich Kommoss, A. du Bois, Olaf Ortmann, M. Gebhardt, Daniel Fink, Felix Hilpert, P. Ortner, Diana Lüftner, W Meier, P. Piso, Joachim Weis, B. Radeleff, Klaus König, Dieter Grab, Edgar Petru, IB Runnebaum, N. Frickhofen, F. Grünwald, P. Harter, B. O. Maier, Sven Mahner, Jacobus Pfisterer, Norbert Arnold, C. Eggert, K. Lindel, Steffen Hauptmann, G. Emons, Uwe Wagner, A Reuß, Alexander Burges, Joachim Diebold, I. Weisse, Jalid Sehouli
Rok vydání: 2013
Předmět:
Zdroj: Geburtshilfe und Frauenheilkunde. 73:874-889
ISSN: 1438-8804
0016-5751
Popis: 2.1 Target audience The guideline was compiled with the aim of providing high-risk groups with advice on diagnostics, surgical and systemic therapy in early and advanced stages of disease together with the treatment of rare histological subtypes. A lot of emphasis has been placed on follow-up care, rehabilitation, palliative therapy and psycho-oncological counselling. The recommendations are for physicians working both in hospitals and outpatient clinics, nursing staff and other medical partners involved in treating patients with malignant ovarian tumours. As it also covers the topics ‘Screening’ and ‘Follow-up’, registered physicians working in their own practice are also an important target audience of this guideline. It is additionally intended to offer guidance to affected patients and persons seeking more information as well as providing a basis for the gynaecological cancer centres currently being set up in Germany. For the first time, scientific medical societies in Switzerland and Austria were also consulted, expanding the scope of this guideline.
Databáze: OpenAIRE